Variant report

Variant	rs35158421
Chromosome Location	chr12:121533445-121533446
allele	A/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:121447247..121448275-chr12:121533293..121534356,3	MCF-7	breast:
2	chr12:121498108..121499039-chr12:121533443..121534521,4	MCF-7	breast:
3	chr12:121020917..121021868-chr12:121533219..121533885,3	K562	blood:
4	chr12:121531941..121534103-chr12:121555507..121557731,2	K562	blood:
5	chr12:121533067..121535799-chr12:121628437..121630049,2	K562	blood:
6	chr12:121532324..121533988-chr12:121647782..121650405,2	MCF-7	breast:
7	chr12:121528483..121531655-chr12:121531657..121534218,3	MCF-7	breast:
8	chr12:121525079..121528154-chr12:121532572..121535295,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000135124	Chromatin interaction

Extended variants
information (count: 90 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:77)

rs_ID	r²[population]
rs12810503	0.82[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs12813980	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs12814235	0.82[AMR][1000 genomes]
rs12816966	0.82[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs12817169	0.86[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs12819523	0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs12819930	0.97[ASN][1000 genomes]
rs12820593	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs12824585	0.82[AMR][1000 genomes]
rs12830584	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs12832396	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs1718153	0.82[AMR][1000 genomes];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs17432871	0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs17434640	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs17525809	0.88[ASN][1000 genomes]
rs208302	0.82[ASN][1000 genomes]
rs2260138	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs2393752	0.93[ASN][1000 genomes]
rs2393753	0.82[ASN][1000 genomes]
rs2393754	0.85[ASN][1000 genomes]
rs2464844	0.85[ASN][1000 genomes]
rs28969465	0.82[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs28969469	0.82[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs34185850	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs34325588	0.82[AMR][1000 genomes]
rs34449339	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs34480856	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs34572498	0.88[ASN][1000 genomes]
rs34805626	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs34811727	0.82[AMR][1000 genomes]
rs34934130	0.82[AMR][1000 genomes]
rs35018823	0.88[ASN][1000 genomes]
rs35076950	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs35237790	0.82[AMR][1000 genomes]
rs35362296	0.82[AMR][1000 genomes]
rs35455367	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.87[ASN][1000 genomes]
rs35579189	0.82[AMR][1000 genomes];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs35605477	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs35760636	0.93[ASN][1000 genomes]
rs35869834	0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs35940217	0.82[AMR][1000 genomes]
rs36133237	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs494986	0.93[ASN][1000 genomes]
rs513113	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs514109	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs56047892	0.94[AFR][1000 genomes]
rs56098349	0.82[AFR][1000 genomes];0.93[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs583187	0.93[ASN][1000 genomes]
rs585847	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs588130	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs588510	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs588573	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs599785	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs601636	0.88[ASN][1000 genomes]
rs603505	0.85[ASN][1000 genomes]
rs603891	0.82[AMR][1000 genomes];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs618201	0.82[AMR][1000 genomes];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs657172	0.93[ASN][1000 genomes]
rs66570654	0.82[AMR][1000 genomes];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs66811517	0.82[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs670541	0.81[AMR][1000 genomes];0.92[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs675718	0.93[ASN][1000 genomes]
rs676632	0.93[ASN][1000 genomes]
rs67691679	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs67739439	0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs67881993	0.93[ASN][1000 genomes]
rs67898046	0.82[AMR][1000 genomes]
rs71454676	0.81[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs71454679	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs71454680	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs73214191	0.82[AMR][1000 genomes]
rs73214199	0.82[AMR][1000 genomes]
rs73216114	0.82[AMR][1000 genomes];0.87[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs73218241	0.82[AMR][1000 genomes];0.88[ASN][1000 genomes]
rs934353	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.90[ASN][1000 genomes]
rs934354	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs934355	0.82[AMR][1000 genomes];0.83[EUR][1000 genomes];0.88[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:13 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv521928	chr12:121041728-121761800	Genic enhancers Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' Enhancers Strong transcription ZNF genes & repeats Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	68 gene(s)	inside rSNPs	diseases
2	nsv899559	chr12:121324727-121592689	Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Genic enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	31 gene(s)	inside rSNPs	diseases
3	nsv899560	chr12:121371233-121560581	Strong transcription Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	23 gene(s)	inside rSNPs	diseases
4	nsv899562	chr12:121376416-121565870	Weak transcription Flanking Active TSS Active TSS Strong transcription Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
5	esv2758318	chr12:121415845-121584813	Weak transcription Flanking Active TSS Strong transcription Enhancers Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
6	esv2759917	chr12:121415845-121584813	Enhancers Weak transcription ZNF genes & repeats Active TSS Flanking Active TSS Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
7	nsv1039216	chr12:121421701-121538491	Active TSS Flanking Active TSS Enhancers Strong transcription Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	13 gene(s)	inside rSNPs	diseases
8	nsv832531	chr12:121440495-121604232	Flanking Active TSS Enhancers Active TSS Strong transcription Weak transcription Genic enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases
9	nsv560454	chr12:121457073-121745742	Strong transcription Enhancers Active TSS Weak transcription Flanking Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	29 gene(s)	inside rSNPs	diseases
10	nsv430537	chr12:121487632-121579955	Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Flanking Active TSS Weak transcription Genic enhancers ZNF genes & repeats Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	8 gene(s)	inside rSNPs	diseases
11	nsv1054878	chr12:121519880-121761800	Flanking Active TSS Genic enhancers Strong transcription Weak transcription Enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
12	nsv455729	chr12:121525591-121761800	Enhancers Strong transcription Genic enhancers Flanking Active TSS Weak transcription Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	25 gene(s)	inside rSNPs	diseases
13	nsv560455	chr12:121525591-121761800	Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	25 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:112 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:121531000-121534400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
2	chr12:121533000-121534600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
3	chr12:121533200-121533600	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
4	chr12:121533200-121533600	Bivalent Enhancer	Fetal Stomach	stomach
5	chr12:121533200-121533800	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
6	chr12:121533200-121533800	Flanking Active TSS	Duodenum Mucosa	Duodenum
7	chr12:121533200-121533800	Flanking Bivalent TSS/Enh	A549	lung
8	chr12:121533200-121534000	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
9	chr12:121533200-121534000	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
10	chr12:121533200-121534000	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
11	chr12:121533200-121534000	Enhancers	Left Ventricle	heart
12	chr12:121533200-121534000	Enhancers	Stomach Mucosa	stomach
13	chr12:121533200-121534200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
14	chr12:121533200-121534200	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
15	chr12:121533200-121534200	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
16	chr12:121533200-121534400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
17	chr12:121533200-121534400	Enhancers	Fetal Thymus	thymus
18	chr12:121533200-121534600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr12:121533200-121534600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
20	chr12:121533400-121533600	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
21	chr12:121533400-121533600	Bivalent/Poised TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr12:121533400-121533600	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
23	chr12:121533400-121533600	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr12:121533400-121533600	Enhancers	Primary B cells from cord blood	blood
25	chr12:121533400-121533600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
26	chr12:121533400-121533600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr12:121533400-121533600	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
28	chr12:121533400-121533600	Flanking Active TSS	Brain Hippocampus Middle	brain
29	chr12:121533400-121533600	Flanking Bivalent TSS/Enh	Duodenum Smooth Muscle	Duodenum
30	chr12:121533400-121533600	Bivalent Enhancer	Fetal Intestine Large	intestine
31	chr12:121533400-121533600	Flanking Bivalent TSS/Enh	Fetal Intestine Small	intestine
32	chr12:121533400-121533600	Enhancers	Pancreas	Pancrea
33	chr12:121533400-121533600	Active TSS	Psoas Muscle	Psoas
34	chr12:121533400-121533600	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
35	chr12:121533400-121533600	Active TSS	Rectal Smooth Muscle	rectum
36	chr12:121533400-121533600	Enhancers	Right Atrium	heart
37	chr12:121533400-121533600	Bivalent Enhancer	Thymus	Thymus
38	chr12:121533400-121533600	Bivalent/Poised TSS	K562	blood
39	chr12:121533400-121533800	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr12:121533400-121533800	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr12:121533400-121533800	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr12:121533400-121533800	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
43	chr12:121533400-121533800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
44	chr12:121533400-121533800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
45	chr12:121533400-121533800	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr12:121533400-121533800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
47	chr12:121533400-121533800	Flanking Bivalent TSS/Enh	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
48	chr12:121533400-121533800	Flanking Active TSS	Primary B cells from peripheral blood	blood
49	chr12:121533400-121533800	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
50	chr12:121533400-121533800	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links